121 related articles for article (PubMed ID: 9781039)
21. Linkage of a locus for carbohydrate-deficient glycoprotein syndrome type I (CDG1) to chromosome 16p, and linkage disequilibrium to microsatellite marker D16S406.
Martinsson T; Bjursell C; Stibler H; Kristiansson B; Skovby F; Jaeken J; Blennow G; Strömme P; Hanefeld F; Wahlström J
Hum Mol Genet; 1994 Nov; 3(11):2037-42. PubMed ID: 7874123
[TBL] [Abstract][Full Text] [Related]
22. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).
Matthijs G; Schollen E; Bjursell C; Erlandson A; Freeze H; Imtiaz F; Kjaergaard S; Martinsson T; Schwartz M; Seta N; Vuillaumier-Barrot S; Westphal V; Winchester B
Hum Mutat; 2000 Nov; 16(5):386-94. PubMed ID: 11058895
[TBL] [Abstract][Full Text] [Related]
23. [Metabolic disorders in patients with primary carbohydrate deficient glycoprotein syndrome].
Zwierz K; Midro AT
Postepy Hig Med Dosw; 1997; 51(2):205-26. PubMed ID: 9235566
[TBL] [Abstract][Full Text] [Related]
24. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I.
Van Schaftingen E; Jaeken J
FEBS Lett; 1995 Dec; 377(3):318-20. PubMed ID: 8549746
[TBL] [Abstract][Full Text] [Related]
25. Congenital disorder of glycosylation type 1a: three siblings with a mild neurological phenotype.
Coman D; McGill J; MacDonald R; Morris D; Klingberg S; Jaeken J; Appleton D
J Clin Neurosci; 2007 Jul; 14(7):668-72. PubMed ID: 17451957
[TBL] [Abstract][Full Text] [Related]
26. Prenatal diagnosis and the subsequent mutation analysis in a family with carbohydrate-deficient glycoprotein type I syndrome: growing evidence to support founder effects within CDG1 populations.
Crosby A; Jeffery S; Homfray T; Taylor R; Patton M
Genet Test; 1999; 3(3):305-7. PubMed ID: 10495932
[TBL] [Abstract][Full Text] [Related]
27. Kinetic properties and tissular distribution of mammalian phosphomannomutase isozymes.
Pirard M; Achouri Y; Collet JF; Schollen E; Matthijs G; Van Schaftingen E
Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):201-7. PubMed ID: 10085245
[TBL] [Abstract][Full Text] [Related]
28. Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology.
Aronica E; van Kempen AA; van der Heide M; Poll-The BT; van Slooten HJ; Troost D; Rozemuller-Kwakkel JM
Acta Neuropathol; 2005 Apr; 109(4):433-42. PubMed ID: 15714316
[TBL] [Abstract][Full Text] [Related]
29. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
30. Evidence for genetic heterogeneity in the carbohydrate-deficient glycoprotein syndrome type I (CDG1).
Matthijs G; Legius E; Schollen E; Vandenberk P; Jaeken J; Barone R; Fiumara A; Visser G; Lambert M; Cassiman JJ
Genomics; 1996 Aug; 35(3):597-9. PubMed ID: 8812498
[TBL] [Abstract][Full Text] [Related]
31. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
32. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.
Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH
Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417
[TBL] [Abstract][Full Text] [Related]
33. Denaturing high-performance liquid chromatography is a suitable method for PMM2 mutation screening in carbohydrate-deficient glycoprotein syndrome type IA patients.
Erlandson A; Stibler H; Kristiansson B; Wahlström J; Martinsson T
Genet Test; 2000; 4(3):293-7. PubMed ID: 11142762
[TBL] [Abstract][Full Text] [Related]
34. CDG type Ia and congenital cytomegalovirus infection: two coexisting conditions.
Jamroz E; Adamek D; Paprocka J; Adamowicz M; Marszał E; Wevers RA
J Child Neurol; 2009 Jan; 24(1):13-8. PubMed ID: 19168813
[TBL] [Abstract][Full Text] [Related]
35. Increased recurrence risk in congenital disorders of glycosylation type Ia (CDG-Ia) due to a transmission ratio distortion.
Schollen E; Kjaergaard S; Martinsson T; Vuillaumier-Barrot S; Dunoe M; Keldermans L; Seta N; Matthijs G
J Med Genet; 2004 Nov; 41(11):877-80. PubMed ID: 15520415
[No Abstract] [Full Text] [Related]
36. Comparative analysis of the phosphomannomutase genes PMM1, PMM2 and PMM2psi: the sequence variation in the processed pseudogene is a reflection of the mutations found in the functional gene.
Schollen E; Pardon E; Heykants L; Renard J; Doggett NA; Callen DF; Cassiman JJ; Matthijs G
Hum Mol Genet; 1998 Feb; 7(2):157-64. PubMed ID: 9425221
[TBL] [Abstract][Full Text] [Related]
37. Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds.
Smith BN; Ancliff PJ; Pizzey A; Khwaja A; Linch DC; Gale RE
Br J Haematol; 2009 Mar; 144(5):762-70. PubMed ID: 19036076
[TBL] [Abstract][Full Text] [Related]
38. Effect of mutations found in carbohydrate-deficient glycoprotein syndrome type IA on the activity of phosphomannomutase 2.
Pirard M; Matthijs G; Heykants L; Schollen E; Grünewald S; Jaeken J; van Schaftingen E
FEBS Lett; 1999 Jun; 452(3):319-22. PubMed ID: 10386614
[TBL] [Abstract][Full Text] [Related]
39. Mutation analysis in nephronophthisis using a combined approach of homozygosity mapping, CEL I endonuclease cleavage, and direct sequencing.
Otto EA; Helou J; Allen SJ; O'Toole JF; Wise EL; Ashraf S; Attanasio M; Zhou W; Wolf MT; Hildebrandt F
Hum Mutat; 2008 Mar; 29(3):418-26. PubMed ID: 18076122
[TBL] [Abstract][Full Text] [Related]
40. Carbohydrate-deficient glycoprotein syndromes.
Kościelak J
Acta Biochim Pol; 1999; 46(3):727-38. PubMed ID: 10698281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
